000 01410 a2200409 4500
005 20250518040922.0
264 0 _c20200818
008 202008s 0 0 eng d
022 _a1029-2330
024 7 _a10.1080/1061186X.2019.1608553
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSalem, Heba F
245 0 0 _aBrain targeting of resveratrol through intranasal lipid vesicles labelled with gold nanoparticles:
_h[electronic resource]
260 _bJournal of drug targeting
_c12 2019
300 _a1127-1134 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Intranasal
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aBioaccumulation
_xdrug effects
650 0 4 _aBrain
_xdrug effects
650 0 4 _aGold
_xchemistry
650 0 4 _aLipids
_xchemistry
650 0 4 _aMale
650 0 4 _aMetal Nanoparticles
_xchemistry
650 0 4 _aNeuroprotective Agents
_xchemistry
650 0 4 _aParticle Size
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aResveratrol
_xchemistry
650 0 4 _aTomography, X-Ray Computed
_xmethods
700 1 _aKharshoum, Rasha M
700 1 _aAbou-Taleb, Heba A
700 1 _aNaguib, Demiana M
773 0 _tJournal of drug targeting
_gvol. 27
_gno. 10
_gp. 1127-1134
856 4 0 _uhttps://doi.org/10.1080/1061186X.2019.1608553
_zAvailable from publisher's website
999 _c29695607
_d29695607